Table 6.
3 weeks after treatment | 6 weeks after treatment | ||||||
---|---|---|---|---|---|---|---|
Baseline | Total | Positive | Indecisive | Negative | Positive | Indecisive | Negative |
UCAA2000a | |||||||
Positive | 44 | 32 | 4 | 8 | 27 | 8 | 9 |
Indecisive | 6 | 0 | 0 | 6 | 1 | 0 | 5 |
Negative | 78 | 2 | 2 | 73 | 7 | 22 | 49 |
Total | 128 | 34 | 6 | 87 | 35 | 30 | 63 |
Positivity | 34% | 27% | 27% | ||||
SCAA500b | |||||||
Positive | 39 | 12 | 6 | 18 | 10 | 5 | 21 |
Indecisive | 7 | 1 | 0 | 6 | 0 | 0 | 7 |
Negative | 82 | 0 | 0 | 76 | 1 | 2 | 78 |
Total | 128 | 13 | 6 | 100 | 11 | 7 | 106 |
Positivity | 31% | 11% | 8.9% |
One patient have no UCAA2000 result at 3 weeks after treatment.
Nine and four patients have no SCAA500 results at 3 and 6-weeks after treatment, respectively.